Literature DB >> 29024771

Development of dot-ELISA for the detection of venoms of major Indian venomous snakes.

Innus K Shaikh1, Prashant P Dixit2, Balasaheb S Pawade3, Indrasen G Waykar3.   

Abstract

India remained an epicenter for the snakebite-related mortality and morbidities due to widespread agricultural activities across the country and a considerable number of snakebites offended by Indian cobra (Naja naja), common krait (Bungarus caeruleus), Russell's viper (Daboia russelii), and saw-scaled viper (Echis carinatus). Presently, there is no selective test available for the detection of snake envenomation in India before the administration of snake antivenin. Therefore, the present study aimed to develop rapid, sensitive assay for the management of snakebite, which can detect venom, responsible snake species and serve as a tool for the reasonable administration of snake antivenin, which have scarcity across the world. The selective envenomation detection assay needs venom specific antibodies (VSAbs) for that monovalent antisera was prepared by hyperimmunization of rabbits with specific venom. However, obtained antibodies exhibit maximum activity towards homologous venom as well as quantifiable degree of cross-reactivity with heterologous venoms. Use of these antibodies for development of selective envenomation detection assay may create ambiguity in results, therefore needs to isolate VSAbs from monovalent antisera. The cross-reacting antibodies were specifically removed by immunoaffinity chromatography to obtain VSAbs. For the development of venom detection ELISA test (VDET), two different species of antibodies were used that offers enhanced sensitivity along with selective identification of the venoms of the responsible snakes. In conclusion, the developed VDET is rapid, specific, yet sensitive to detect venoms of offending snake species, and its venom concentration down to 1.0 ng/ml. However, the device observed with lowest venom concentration detection ability in the range <1.0 ng/ml from experimentally envenomated samples. The implementation of VDET will help in avoiding unnecessary usage and adverse reactions of snake antivenin. The test has all the merits to become a choice of method in envenomation diagnosis from medically important snakes of India.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Envenomation; Enzyme-linked immunoassays; Snakebite; Venom detection

Mesh:

Substances:

Year:  2017        PMID: 29024771     DOI: 10.1016/j.toxicon.2017.10.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Rational truncation of aptamer for cross-species application to detect krait envenomation.

Authors:  Abhijeet Dhiman; Anjali Anand; Anita Malhotra; Eshan Khan; Vishal Santra; Amit Kumar; Tarun Kumar Sharma
Journal:  Sci Rep       Date:  2018-12-12       Impact factor: 4.379

2.  Determination of median effective dose (ED50) of scorpion antivenom against scorpion envenomation using a newly developed formula.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  Animal Model Exp Med       Date:  2018-09-25

3.  Development of an Inhibition Enzyme-Linked Immunosorbent Assay (ELISA) Prototype for Detecting Cytotoxic Three-Finger Toxins (3FTxs) in African Spitting Cobra Venoms.

Authors:  Ernest Z Manson; Kyama C Mutinda; Joseph K Gikunju; Aleksandra Bocian; Konrad K Hus; Vladimír Petrílla; Jaroslav Legáth; James H Kimotho
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

Review 4.  Current Knowledge on Snake Dry Bites.

Authors:  Manuela B Pucca; Cecilie Knudsen; Isadora S Oliveira; Charlotte Rimbault; Felipe A Cerni; Fan Hui Wen; Jacqueline Sachett; Marco A Sartim; Andreas H Laustsen; Wuelton M Monteiro
Journal:  Toxins (Basel)       Date:  2020-10-22       Impact factor: 4.546

5.  Assessment of quality and pre-clinical efficacy of a newly developed polyvalent antivenom against the medically important snakes of Sri Lanka.

Authors:  Aparup Patra; Bhargab Kalita; Milind V Khadilkar; Nitin C Salvi; Pravin V Shelke; Ashis K Mukherjee
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.